HCGIV-11: A Promising Pseudogene for Pregnancy and Reproductive Health

Target Name: HCG4P11

NCBI ID: G353020

HCG4P11

Other Name(s): HCGIV-11 pseudogene | HCGIV-11 | HLA complex group 4 pseudogene 11 | HCGIV.10

HCGIV-11: A Promising Pseudogene for Pregnancy and Reproductive Health

Human chorionic gonadotropin (HCG) is a hormone produced by the placenta shortly after fertilization occurs. HCG is a key indicator of pregnancy and is often used as a test for pregnancy, as well as for the diagnosis of ectopic pregnancy and infertility. Despite its importance in medical diagnostics, little is known about the molecular biology and underlying mechanisms of HCG.

One of the most promising promising pseudogenes in the field of HCG is HCGIV-11. HCGIV-11 is a transcribed gene that is located on chromosome 11 and is highly conserved across different species. There is almost no expression in the adult body.

HCGIV-11 has been shown to be involved in the development and maintenance of pregnancy. Studies have shown that HCGIV-11 is highly expressed in the placenta and is responsible for the production of HCG in the early stages of pregnancy. Additionally, HCGIV-11 has been shown to play a role in the regulation of implantation and pregnancy development.

One of the most interesting aspects of HCGIV-11 is its potential as a drug target. The use of HCGIV-11 as a drug target has the potential to revolutionize the field of reproductive medicine. By targeting HCGIV-11, researchers may be able to develop new treatments for infertility and other reproductive health conditions.

HCGIV-11 has also been shown to be a potential biomarker for certain reproductive health conditions. For example, some studies have shown that HCGIV-11 levels may be elevated in women with polycystic ovary syndrome (PCOS), a common reproductive health condition that affects around 10% of women. Additionally, HCGIV-11 has been shown to be elevated in women with endometriosis, a condition that causes infertility and abdominal pain.

In conclusion, HCGIV-11 is a pseudogene that has shown promising potential as a drug target and biomarker in the field of reproductive medicine. Further research is needed to fully understand the role of HCGIV-11 in the development and maintenance of pregnancy, as well as its potential as a drug and biomarker. By studying HCGIV-11, researchers may be able to develop new treatments and diagnostic tools for infertility and other reproductive health conditions.

Protein Name: HLA Complex Group 4 Pseudogene 11

The "HCG4P11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about HCG4P11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets